| New Cell Line Adder to Stem-Cell Research Portfolio |
| |
| |
March 24 2008 |
| |
| |
Thermo Fisher Scientific Adds Key Cell Line to Portfolio of Products Supporting Stem-Cell Research |
| |
Offering Now Includes Multipotent Cord Blood Unrestricted Somatic Stem Cells
LOGAN, Utah, (March 21, 2008) – Thermo Fisher Scientific Inc., the world leader in serving science, is now offering Multipotent Cord Blood Unrestricted Somatic Stem Cells from Cellular Engineering Technologies (CET). These stem cells are important in many research applications, including cultivation of neural-like cells, the study of blood development and, most importantly, research of liver disease, cardiac failure and other health problems.
CET’s Multipotent Cord Blood Unrestricted Somatic Stem Cells (MCBUSSCs) have the potential to differentiate into neural-like cells and osteocytes (nerve cells and bone cells). They are isolated from human umbilical cord blood using differential plating techniques and a proprietary media formulation.
“With the differentiation potential of these cells, MCBUSSCs show promise for research studies into Parkinson’s disease and other neurodegenerative disorders.,” said Alain Fairbank, research market manager for BioProcess Production at Thermo Fisher Scientific. “Thermo Fisher Scientific has tested and qualified these stem cells so researchers can perform more efficient testing. All cells are characterized with a panel of known markers and analyzed by flow cytometry to ensure more than 95 percent purity.”
Through an agreement with CET, Thermo Fisher Scientific is marketing and delivering the stem-cell lines worldwide as a complementary offering to its differentiation kits. This new offering expands the Thermo Scientific HyClone AdvanceSTEM range of cell-nutrition products developed specifically for applications in stem-cell research.
The CET Stem Cells are part of the Thermo Scientific Stem Cell Excellence portfolio, an end-to-end workflow solution that incorporates essential instruments, equipment, consumables, reagents and media, services and software tailored to the needs of stem-cell laboratories. Learn more at www.thermo.com/stemcell.
Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, we have more than 30,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.
About Cellular Engineering Technologies
CET is a biotechnology tissue engineering company, which combines expertise in stem cell science, tissue engineering and preclinical drug discovery applications. CET specializes in stem cells obtained from human non-embryonic sources, such as fat collected during liposuction procedures, umbilical cords, umbilical cord blood, and placentas collected after full-term deliveries. The company was founded by Dr. Alan Moy, CEO, in 2000 and is Iowa's premier non-embryonic stem cell company. Visit www.celleng-tech.com.
|
|
|
|
0 Items